Literature DB >> 24272087

Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma.

Wenqiao Zang1, Yuanyuan Wang, Yuwen Du, Xiaoyan Xuan, Tao Wang, Min Li, Yunyun Ma, Ping Li, Xudong Chen, Ziming Dong, Guoqiang Zhao.   

Abstract

MicroRNAs are small, noncoding RNAs approximately 18-24 nucleotides in length that negatively regulate gene expression at the posttranscriptional and/or translational level by binding to complimentary sequences in the 3'-untranslated regions of target mRNAs. Growing evidence has indicated the important roles for different miRNA species in the development of different cancers. Therefore, miRNAs have the potential to become new biological markers for esophageal squamous cell carcinoma (ESCC) and to be applied in the diagnosis, prognosis, and targeted treatment of ESCC. In this study, we performed a miRNA microarray to analyze the miRNA expression profile in ESCC compared to normal tissues. Then, we made a preliminary analysis of the biological function for the most differentially expressed miRNAs and their potentially target genes regulated. Some microarray results were validated by performing quantitative RT-PCR. The study provided evidence that linked the biological role of miRNAs to ESCC and showed that miRNAs could undertake a variety of mechanisms. Additionally, we also found that altered miR-429 and miR-451 expression levels were associated with the occurrence of lymph node metastases and the differentiation status and TNM stage in ESCC. The study of miRNAs may lead to finding novel methods to diagnose, treat, and prevent ESCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24272087     DOI: 10.1007/s13277-013-1432-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

Review 1.  Control of mitochondrial activity by miRNAs.

Authors:  Peifeng Li; Jianqing Jiao; Guifeng Gao; Bellur S Prabhakar
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

2.  Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

Authors:  Chunni Zhang; Cheng Wang; Xi Chen; Cuihua Yang; Ke Li; Junjun Wang; Juncheng Dai; Zhibin Hu; Xiaojun Zhou; Longbang Chen; Yanni Zhang; Yanfang Li; Hong Qiu; Jicheng Xing; Zhichao Liang; Binhui Ren; Chen Yang; Ke Zen; Chen-Yu Zhang
Journal:  Clin Chem       Date:  2010-10-13       Impact factor: 8.327

3.  An optimized isolation and labeling platform for accurate microRNA expression profiling.

Authors:  Jaclyn Shingara; Kerri Keiger; Jeffrey Shelton; Walairat Laosinchai-Wolf; Patricia Powers; Richard Conrad; David Brown; Emmanuel Labourier
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

Review 4.  Canalization of development by microRNAs.

Authors:  Eran Hornstein; Noam Shomron
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

Review 5.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 6.  Cancer cell metabolism.

Authors:  R A Cairns; I Harris; S McCracken; T W Mak
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-12

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 8.  miRNAs in head and neck cancer revisited.

Authors:  Rahul Nagadia; Pratibala Pandit; William B Coman; Justin Cooper-White; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2013-01-22       Impact factor: 6.730

9.  The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.

Authors:  Po-Kuei Hsu; Chien-Sheng Huang; Bing-Yen Wang; Yu-Chung Wu; Teh-Ying Chou; Wen-Hu Hsu
Journal:  Ann Thorac Surg       Date:  2013-07-16       Impact factor: 4.330

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  16 in total

1.  High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.

Authors:  Chuanli Ren; Hui Chen; Chongxu Han; Deyuan Fu; Daxin Wang; Ming Shen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-07       Impact factor: 4.553

2.  Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Wenjian Yao; Xiuguang Qin; Bo Qi; Jianguo Lu; Ling Guo; Fulei Liu; Shangguo Liu; Baosheng Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1.

Authors:  Wen-Qiao Zang; Xuan Yang; Tao Wang; Yuan-Yuan Wang; Yu-Wen Du; Xiao-Nan Chen; Min Li; Guo-Qiang Zhao
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

5.  miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.

Authors:  Gang Peng; Yiwei Liao; Chenfu Shen
Journal:  Pathol Oncol Res       Date:  2016-09-23       Impact factor: 3.201

6.  Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.

Authors:  Renjie Wu; Yingjiu Jiang; Qingcheng Wu; Qiang Li; Dan Cheng; Ling Xu; Cheng Zhang; Ming Zhang; Ling Ye
Journal:  Tumour Biol       Date:  2014-06-01

7.  Zinc finger A20 and NF-κB correlate with high-risk human papillomavirus of squamous cell carcinoma patients.

Authors:  Ya-Juan Tang; Ahmad Taha Khalaf; Xiao-Ming Liu; Chun-Xing Xu; Wei Zhao; Sai Cheng; Ru-Zhi Zhang
Journal:  Tumour Biol       Date:  2014-09-18

Review 8.  miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Authors:  Emanuela Minna; Paola Romeo; Matteo Dugo; Loris De Cecco; Katia Todoerti; Silvana Pilotti; Federica Perrone; Ettore Seregni; Luca Agnelli; Antonino Neri; Angela Greco; Maria Grazia Borrello
Journal:  Oncotarget       Date:  2016-03-15

Review 9.  Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.

Authors:  Jian Wang; Jiqing Zhao; Mengjing Shi; Yu Ding; Huiqin Sun; Fahuan Yuan; Zhongmin Zou
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.

Authors:  Heath D Skinner; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; Wayne Hofstetter; Ritsuko Komaki; Hironori Shiozaki; Roopma Wadhwa; Kazuki Sudo; Elena Elimova; Shumei Song; Yuanqing Ye; Maosheng Huang; Jaffer Ajani; Xifeng Wu
Journal:  Cancer       Date:  2014-08-04       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.